Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation

Agyeman, A.S., Chaerkady, R., Shaw, P.G., Davidson, N.E., Visvanathan, K., Pandey, A., Kensler, T.W., 2011. Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res. Treat. 2011 [Epub ahead of print]. Albrecht, 2010, Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target, CNS Neurol. Disord.: Drug Targets, 9, 373, 10.2174/187152710791292567 Babior, 1973, Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent, J. Clin. Invest., 52, 741, 10.1172/JCI107236 Baker, 2003, Neuroadaptations in cystine–glutamate exchange underlie cocaine relapse, Nat. Neurosci., 6, 743, 10.1038/nn1069 Bogaard, 2009, Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure, Circulation, 120, 1951, 10.1161/CIRCULATIONAHA.109.883843 Cao, 2006, Antioxidants and phase 2 enzymes in cardiomyocytes: chemical inducibility and chemoprotection against oxidant and simulated ischemia–reperfusion injury, Exp. Biol. Med. (Maywood), 231, 1353, 10.1177/153537020623100809 Chan, 2011, Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential, Clin. Sci. (Lond.), 120, 493, 10.1042/CS20100508 Chen, 2011, GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response, Cancer Lett., 309, 37, 10.1016/j.canlet.2011.05.013 Chen, 2005, Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells, Biochem. Biophys. Res. Commun., 331, 993, 10.1016/j.bbrc.2005.03.237 Cheung, 2010, Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention, AAPS J., 12, 87, 10.1208/s12248-009-9162-8 Church, 1993, Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells, Proc. Natl. Acad. Sci. USA, 90, 3113, 10.1073/pnas.90.7.3113 Cushing, 1973, Orgotein therapy for inflammation in horses, Mod. Vet. Pract., 54, 17 Dinkova-Kostova, 2002, Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants, Proc. Natl. Acad. Sci. USA, 99, 11908, 10.1073/pnas.172398899 Gao, 2003, Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3, Am. J. Physiol. Lung Cell. Mol. Physiol., 284, L917, 10.1152/ajplung.00374.2002 Gerschman, 1954, Oxygen poisoning and X-irradiation: a mechanism in common, Science, 119, 623, 10.1126/science.119.3097.623 Giudice, 2006, Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention, Bioessays, 28, 169, 10.1002/bies.20359 Granger, 1981, Superoxide radicals in feline intestinal ischemia, Gastroenterology, 81, 22, 10.1016/0016-5085(81)90648-X Harman, 1956, Aging: a theory based on free radical and radiation chemistry, J. Gerontol., 11, 298, 10.1093/geronj/11.3.298 Hernandez-Saavedra, 2005, Anti-inflammatory properties of a chimeric recombinant superoxide dismutase: SOD2/3, Biomed. Pharmacother., 59, 204, 10.1016/j.biopha.2005.03.001 Howitz, 2003, Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature, 425, 191, 10.1038/nature01960 Hu, 2010, Regulation of Nrf2 signaling for cancer chemoprevention: antioxidant coupled with anti-inflammatory, Antioxid. Redox Signal., 13, 1679, 10.1089/ars.2010.3276 Huang, 2002, Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription, J. Biol. Chem., 277, 42769, 10.1074/jbc.M206911200 Huber, 1968, Some chemical and pharmacologic properties of a novel anti-inflammatory protein, Toxicol. Appl. Pharmacol., 12, 308 Itoh, 1999, Regulatory mechanisms of cellular response to oxidative stress, Free Radic. Res., 31, 319, 10.1080/10715769900300881 Itoh, 2004, Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2), Mol. Cell. Biol., 24, 36, 10.1128/MCB.24.1.36-45.2004 Itoh, 1999, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev., 13, 76, 10.1101/gad.13.1.76 Kang, 2011, Autophagy impairment induces premature senescence in primary human fibroblasts, PLoS ONE, 6, e23367, 10.1371/journal.pone.0023367 Kang, 2002, Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress, Mol. Pharmacol., 62, 1001, 10.1124/mol.62.5.1001 Kappos, 2008, Efficacy and safety of oral fumarate in patients with relapsing–remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study, Lancet, 372, 1463, 10.1016/S0140-6736(08)61619-0 Kawai, 2011, Acetylation–deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization, J. Biol. Chem., 286, 7629, 10.1074/jbc.M110.208173 Kikuchi, 2010, Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance, Respir. Res., 11, e31, 10.1186/1465-9921-11-31 Liu, 2009, Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model, PLoS ONE, 4, e5284, 10.1371/journal.pone.0005284 Ludwig, 1991, Evaluation of conservative therapeutic approaches to Peyronie’s disease (fibrotic induration of the penis), Urol. Int., 47, 236, 10.1159/000282228 Macmanus, 2011, BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis, J. Neurol., 258, 449, 10.1007/s00415-010-5777-z Marberger, 1975, Orgotein: a new drug for the treatment of radiation cystitis, Curr. Ther. Res., 18, 466 McCord, 1974, Free radicals and inflammation: protection of synovial fluid by superoxide dismutase, Science, 185, 529, 10.1126/science.185.4150.529 McCord, 1985, The role of superoxide in post-ischemic tissue injury, vol. III, 143 McCord, 1968, The reduction of cytochrome c by milk xanthine oxidase, J. Biol. Chem., 243, 5753, 10.1016/S0021-9258(18)91929-0 McCord, 1969, Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein), J. Biol. Chem., 244, 6049, 10.1016/S0021-9258(18)63504-5 McCord, 1971, An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase, Proc. Natl. Acad. Sci. USA, 68, 1024, 10.1073/pnas.68.5.1024 McCord, 1980, Superoxide and inflammation: a mechanism for the anti-inflammatory activity of superoxide dismutase, Acta Physiol. Scand. Suppl., 492, 25 McGinness, 1977, Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase), Physiol. Chem. Phys., 10, 267 McIlwain, 1989, Intra-articular orgotein in osteoarthritis of the knee: a placebo-controlled efficacy, safety, and dosage comparison, Am. J. Med., 87, 295, 10.1016/S0002-9343(89)80154-8 Moi, 1994, Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region, Proc. Natl. Acad. Sci. USA, 91, 9926, 10.1073/pnas.91.21.9926 Natsch, 2008, Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals, Toxicol. Sci., 102, 110, 10.1093/toxsci/kfm259 Nelson, 2006, The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy, Free Radic. Biol. Med., 40, 341, 10.1016/j.freeradbiomed.2005.08.043 Numazawa, 2003, Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress, Am. J. Physiol. Cell Physiol., 285, C334, 10.1152/ajpcell.00043.2003 Pergola, 2011, Bardoxolone methyl and kidney function in CKD with type 2 diabetes, N. Engl. J. Med., 365, 327, 10.1056/NEJMoa1105351 Petrone, 1980, Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma, Proc. Natl. Acad. Sci. USA, 77, 1159, 10.1073/pnas.77.2.1159 Qureshi, 2010, The dietary supplement Protandim decreases plasma osteopontin and markers of oxidative damage in muscular dystrophy mdx mice, J. Diet. Suppl., 7, 159, 10.3109/19390211.2010.482041 Robbins, 2010, The chemopreventive effects of Protandim: modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesis, PLoS ONE, 5, e11902, 10.1371/journal.pone.0011902 Salin, 1975, Free radicals and inflammation. Protection of phagocytosine leukocytes by superoxide dismutase, J. Clin. Invest., 56, 1319, 10.1172/JCI108208 Sanchiz, 1996, Prevention of radioinduced cystitis by orgotein: a randomized study, Anticancer Res., 16, 2025 Seidel, K., Vinet, J., den Dunnen, W.F., Brunt, E.R., Meister, M., Boncoraglio, A., Zijlstra, M.P., Boddeke, H.W., Rub, U., Kampinga, H.H., Carra, S., 2011. The HSPB8–BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases. Neuropathol. Appl. Neurobiol. 2011. doi:10.1111/j.1365-2990.2011.01198.x [Epub ahead of print]. Surh, 2008, Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals, Planta Med., 74, 1526, 10.1055/s-0028-1088302 Tai, 2002, Prostaglandin catabolizing enzymes, Prostaglandins Other Lipid Mediat., 68–69, 483, 10.1016/S0090-6980(02)00050-3 Tang, 2011, Species difference of CD137 ligand signaling in human and murine monocytes, PLoS ONE, 6, e16129, 10.1371/journal.pone.0016129 Tomobe, K., Shinozuka, T., Kuroiwa, M., Nomura, Y., 2011. Age-related changes of Nrf2 and phosphorylated GSK-3beta in a mouse model of accelerated aging (SAMP8). Arch. Gerontol. Geriatr. 2011 [Epub ahead of print]. Ungvari, 2010, Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2, Am. J. Physiol. Heart Circ. Physiol., 299, H18, 10.1152/ajpheart.00260.2010 Ungvari, 2011, Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of Nrf2-mediated antioxidant response, Am. J. Physiol. Heart Circ. Physiol., 301, H363, 10.1152/ajpheart.01134.2010 Velmurugan, 2009, Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim, Free Radic. Biol. Med., 46, 430, 10.1016/j.freeradbiomed.2008.10.050 Venugopal, 1996, Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene, Proc. Natl. Acad. Sci. USA, 93, 14960, 10.1073/pnas.93.25.14960 Vetrone, 2009, Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta, J. Clin. Invest., 119, 1583, 10.1172/JCI37662 Wang, 2006, Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of Nrf2 by cancer chemotherapeutic agents, Cancer Res., 66, 10983, 10.1158/0008-5472.CAN-06-2298 Wei, 2011, Pharmacological induction of leukotriene B4-12-hydroxydehydrogenase suppresses the oncogenic transformation of human hepatoma HepG2 cells, Int. J. Oncol., 39, 735 Wild, 1999, Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2, J. Biol. Chem., 274, 33627, 10.1074/jbc.274.47.33627 Wilms, 2010, Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation, J. Neuroinflamm., 7, 30, 10.1186/1742-2094-7-30 Wu, 2004, AMID is a p53-inducible gene downregulated in tumors, Oncogene, 23, 6815, 10.1038/sj.onc.1207909 Wu, 2004, A model-based background adjustment for oligonucleotide expression arrays, J. Am. Stat. Assoc., 99, 909, 10.1198/016214504000000683 Yao, 2008, Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis, J. Biol. Chem., 283, 20060, 10.1074/jbc.M802940200 Yates, 2009, Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid treated mice, Carcinogenesis, 30, 1024, 10.1093/carcin/bgp100 Yu, 1999, Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals, J. Biol. Chem., 274, 27545, 10.1074/jbc.274.39.27545 Zheng, 2009, Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog, Circulation, 119, 2086, 10.1161/CIRCULATIONAHA.108.826230 Zhong, 2009, Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels, Biochem. Biophys. Res. Commun., 387, 245, 10.1016/j.bbrc.2009.06.123